abstract |
The invention relates to 4-aryl-6-piperazin-1-yl-3-substituted pyridazines, which are rapidly dissociating dopamine 2 receptor antagonists. The compounds described are used as medicaments for the treatment or prevention of disorders of the central nervous system, for example schizophrenia, due to the fact that they exhibit antipsychotic effects without side motor effects. |